TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
1-Year Return
35.44%
This Quarter Return
+13.78%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$204M
AUM Growth
-$108M
(-35%)
Cap. Flow
-$126M
Cap. Flow
% of AUM
-61.96%
Top 10 Holdings %
Top 10 Hldgs %
69.16%
Holding
65
New
4
Increased
5
Reduced
14
Closed
41
Top Buys
| 1 |
Ascendis Pharma
ASND
|
$12.5M |
| 2 |
Biogen
BIIB
|
$11.9M |
| 3 |
Legend Biotech
LEGN
|
$6.15M |
| 4 |
Scholar Rock
SRRK
|
$3.89M |
| 5 |
argenx
ARGX
|
$3.74M |
Top Sells
| 1 |
Amgen
AMGN
|
$28.9M |
| 2 |
DexCom
DXCM
|
$24.9M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$19.3M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$8.75M |
| 5 |
West Pharmaceutical
WST
|
$8.42M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| 3 | Energy | 0% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amylyx Pharmaceuticals
AMLX
$873M
| – | – |
-282,862
| Closed | -$5.18M |
|
27
Amphenol
APH
$136B
| – | – |
-5,164
| Closed | -$217K |
|
28
Healthpeak Properties
DOC
$12.4B
| – | – |
-10,215
| Closed | -$188K |
|
|
29
DexCom
DXCM
$31.3B
| – | – |
-267,380
| Closed | -$24.9M |
|
30
Editas Medicine
EDIT
$218M
| – | – |
-19,295
| Closed | -$151K |
|
31
Elevance Health
ELV
$70.4B
| – | – |
-568
| Closed | -$247K |
|
32
89bio
ETNB
$1.33B
| – | – |
-249,571
| Closed | -$3.85M |
|
33
Fastenal
FAST
$56.8B
| – | – |
-7,328
| Closed | -$200K |
|
34
GCM Grosvenor
GCMG
$677M
| – | – |
-10,229
| Closed | -$79.4K |
|
35
Geron
GERN
$893M
| – | – |
-381,081
| Closed | -$808K |
|
36
Glaukos
GKOS
$5.25B
| – | – |
-56,230
| Closed | -$4.23M |
|
37
Hartford Financial Services
HIG
$37.7B
| – | – |
-3,500
| Closed | -$248K |
|
38
Hershey
HSY
$37.5B
| – | – |
-1,020
| Closed | -$204K |
|
39
Ironwood Pharmaceuticals
IRWD
$171M
| – | – |
-10,326
| Closed | -$99.4K |
|
40
Intuitive Surgical
ISRG
$159B
| – | – |
-8,353
| Closed | -$2.44M |
|
41
Illinois Tool Works
ITW
$76.6B
| – | – |
-932
| Closed | -$215K |
|
42
JetBlue
JBLU
$1.97B
| – | – |
-14,952
| Closed | -$68.8K |
|
43
Kenvue
KVUE
$39.2B
| – | – |
0
| – | – |
|
44
Newmark Group
NMRK
$3.11B
| – | – |
-11,417
| Closed | -$73.4K |
|
45
Nuvalent
NUVL
$5.69B
| – | – |
-113,528
| Closed | -$5.22M |
|
46
PMV Pharmaceuticals
PMVP
$79.5M
| – | – |
-821,384
| Closed | -$5.04M |
|
47
Prospect Capital
PSEC
$1.33B
| – | – |
-27,957
| Closed | -$169K |
|
48
RPC Inc
RES
$1.03B
| – | – |
-12,071
| Closed | -$108K |
|
49
Recursion Pharmaceuticals
RXRX
$1.96B
| – | – |
-22,471
| Closed | -$172K |
|
50
Schrodinger
SDGR
$1.38B
| – | – |
-8,316
| Closed | -$235K |
|